Picture of Korsana Biosciences logo

KRSA — Korsana Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Cyclerion Therapeutics - Net Loss Was Approximately $16.2 Mln For Q2 2021

July 29 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION THERAPEUTICS - NET LOSS WAS APPROXIMATELY $16.2
MILLION FOR Q2 2021
    * CYCLERION THERAPEUTICS - CASH, EQUIVALENTS, RESTRICTED
CASH
BALANCE ON JUNE 30, 2021 ABOUT $70 MILLION VERSUS ABOUT $45
MILLION ON MARCH 31, 2021

Source text: (https://bit.ly/3l6YGwB)
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Korsana Biosciences

See all news